Research programme: Alzheimer's disease diagnostics - Avid Radiopharmaceuticals

Drug Profile

Research programme: Alzheimer's disease diagnostics - Avid Radiopharmaceuticals

Alternative Names: Tau tangle diagnostic program

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Avid Radiopharmaceuticals; Siemens Medical Solutions
  • Developer Avid Radiopharmaceuticals
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alzheimer's disease

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Alzheimer's-disease(Diagnosis) in USA
  • 17 Apr 2013 Preclinical development is ongoing the USA
  • 23 Mar 2010 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route) (Bayer/Avid collaboration)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top